Overview
Peter Barth is a Hematologist and an Oncologist in Providence, Rhode Island. Dr. Barth is highly rated in 15 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Essential Thrombocythemia, and Childhood Iron Deficiency Anemia.
His clinical research consists of co-authoring 17 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
164 Summit Ave, Providence, RI 02906
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Dana-Farber Cancer Institute
Steven Dubois is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Dubois is highly rated in 11 conditions, according to our data. His top areas of expertise are Ewing Sarcoma, Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.
Massachusetts General Hospital
Andrew Yee is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Yee is highly rated in 15 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Vertebroplasty, and Bone Marrow Aspiration.
Rhode Island Hospital
Patrick Mcgann is a Hematologist and an Oncologist in Providence, Rhode Island. Dr. Mcgann is highly rated in 7 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Anemia, Hemolytic Anemia, and Congenital Hemolytic Anemia.
Frequently Asked Questions about Dr. Peter Barth
How do I make an appointment with Dr. Peter Barth?
You can book an appointment with Dr. Peter Barth by calling their office at 401-793-2920. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Peter Barth a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Peter Barth is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Peter Barth specialize in?
While Dr. Peter Barth is a Hematology, they have specific expertise in Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Essential Thrombocythemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Peter Barth participate in research or clinical trials?
Yes. Dr. Peter Barth has published 17 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Peter Barth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Peter Barth accept my insurance?
Dr. Peter Barth accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 401-793-2920 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Essential ThrombocythemiaDr. Barth isDistinguished. Learn about Essential Thrombocythemia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Barth isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Autoimmune Hemolytic AnemiaDr. Barth isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Childhood Iron Deficiency Anemia
- Chronic B-Cell Leukemia (CBCL)Dr. Barth isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Follicular LymphomaDr. Barth isAdvanced. Learn about Follicular Lymphoma.
- Hemangioma Thrombocytopenia Syndrome
- Experienced
- Acute Eosinophilic PneumoniaDr. Barth isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Barth isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Barth isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Barth isExperienced. Learn about Agranulocytosis.